Rationale for Use of an FDA-Cleared Delivery System for Administration of Inhaled Nitric Oxide in Patients Undergoing Magnetic Resonance Imaging

Inhaled nitric oxide (iNO) is a pulmonary vasodilator approved for use to improve lung function in neonates >34 weeks’ gestational age with hypoxic respiratory failure and pulmonary hypertension. Infants with severe respiratory disease frequently require magnetic resonance imaging (MRI) scans for...

Descripción completa

Detalles Bibliográficos
Autores principales: Salas, Mauro, Potenziano, Jim L, Acker, Jaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7800703/
https://www.ncbi.nlm.nih.gov/pubmed/33442306
http://dx.doi.org/10.2147/MDER.S265099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7800703/
https://www.ncbi.nlm.nih.gov/pubmed/33442306
http://dx.doi.org/10.2147/MDER.S265099

Ejemplares similares